Sun Pharmaceutical Industries Ltd.
Mr Dilip Shanghvi, 66, is the Managing Director of Sun Pharmaceutical Industries Ltd, world's 4th largest and India's No 1. generic pharmaceutical company. He is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in R&D of new innovative drugs and delivery technologies.
He was awarded the Padma Shri in 2016 for his distinguished contribution to the Indian Trade & Industry. In January 2018, the Indian government appointed Mr Shanghvi to the Reserve Bank of India's 21-member central board committee.
Mr. Shanghvi has been conferred with many awards and recognitions. In 2021 & 2020, India Today magazine included him in its annual Power List of 50 influential personalities in India. Some of the other awards/recognitions bestowed on him include Entrepreneur of the Year by All India Management Association (2017), NDTV Business Leader of the Year (2015), Forbes Entrepreneur for the year (2014), Economic Times’ Business Leader of the Year (2014), CNN IBN’s Indian of the Year - Business (2011), Business India's Businessman of the Year (2011) and Ernst and Young's World Entrepreneur of the Year (2011). He has also been awarded the Economic Times' Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18's First Generation Entrepreneur of the Year (2007)
He is a former President of Indian Pharmaceutical Alliance (IPA) and has also served as the chairman of the Board of Governors of Indian Institute of Technology (Bombay). He is a trustee of the Rhodes Scholarship Program at Oxford University.
In 2019, he was conferred with an honorary doctorate by the Tel Aviv University, Israel’s largest and most comprehensive institution of higher learning.
Mr Shanghvi has played a vital role in the globalisation of the Indian pharmaceutical industry and has inspired generations of entrepreneurs in their journey of success.